By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biosearch Technologies today said that it has licensed to Seegene patents covering its BHQ, CAL Fluor, and Quasar technologies.

Under terms of the deal, Novato, Calif.-based Biosearch also will manufacture both research and IVD-grade oligonucleotides for Seegene, a Korean firm that makes PCR-based molecular diagnostic products. Financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.